世界上第一个与大米的合成人血清白蛋白将在武汉中大量生产

This newspaper (reporter Li Sihui and Correspondent Jiang Shenglai) The scientific day -to -day has been learned from the Hubei Provincial Department of Science and Technology recently, the first phase of the Plant Source Recombinant Human Serum Album Industrialization Project Base of Wuhani Biotechnology co, Ltd. According to the person in charge of the Heyuan Biological Project, in July, the equipment will be launched, installed and dedicated to one 其他。希望将在8月30日实现水，电和通风，我们将尝试完成并放置在2026年的第二季度。 Heyuan Bio主席Yang Daichang说，该项目是重组血清注入商业化的重要保证专辑。在促进公司的庞大和可持续发展的同时，它将有助于促进我国创新的制药行业的发展，并有助于发展生物制药行业的新优质生产力。经过多年的不断努力，Heyuan Bio开发了与大米合成的世界上第一个男人白蛋白白蛋白，使“稻米造血”的“仙女”成为现实。目前，由企业植物源重组人血清白蛋白注入开发的生物基础治疗产品的新药物已进入了批准的最后阶段，预计将获得今年市场的批准。应用的指示是肝硬化的低白蛋白血症。 “正如每个GENTG Makabagong Gamot一样，Ang重组人血清白蛋白Ay May May May na Pakinabang Tulad ng Matatag Na Mapagkukunan，Mataas na Biosafety，Nakokontrol na Gastos。” Si Qin Zhijie，首席医务官NG Heyuan Bio，Ay Nagsabi Na Sa Katagalan，是ang beses na ang isang epsyal na sitwasyon sa emerhensiya tulad ng mga pangunahing天然na sakuna ay nangyayari，ang halaman-source重组人血清白蛋白对于确保白蛋白供应很重要。